Tysabri Injections licensed in Europe
The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.